Uppsala Reports editor
@UMCGlobalSafety
Spontaneous adverse event reporting keeps the wheel of pharmacovigilance turning, but poses significant challenges that impact its efficacy. For one, only a fraction of adverse events are reported, and what is reported is of poor quality.
In this episode of Drug Safety Matters, Fredrik Brounéus is joined by Henry Zakumumpa, a researcher at Makerere University in Kampala, Uganda whose qualitative study on factors affecting adverse event reporting in the country has uncovered some surprising findings.